Arama Sonuçları - Olivier Vitse

A phase I trial assessing the safety, pharmacokinetics, cerebrospinal fluid penetrance, and food effect of BTK inhibitor tolebrutinib in healthy volunteers Yazar: Marie‐José Cabanis, Olivier Nicolas, Olivier Vitse, Christelle Jan, Priscilla Brun, Patrick Soubayrol, William B. Smith, Timothy J. Turner, Emmanuel Krupka

Connect to this object online.